L&G Artificial Intelligence UCITS ETF CHF is a equity ETF from L&G tracking the Artificial Intelligence index through physical replication. Domiciled in Ireland and launched in 2019, the fund manages about 1.7 bn € and charges a TER of 0.49% — 49 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
L&G Artificial Intelligence UCITS ETF CHF competes with 175 other products in the same class and region (Equity, Global): it ranks 28th by fund size and 106th by ongoing cost, with a TER of 0.49% against a group median of 0.40%. It has been listed since 2019, 7 years of track record.
On a €10,000 investment the TER costs 49 € a year, against 40 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 25.3% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in CHF. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| Ambarella Inc | 2.7% |
| Astera Labs, Inc. | 2.7% |
| Tempus AI, Inc. Class A Common Stock | 2.6% |
| Teradyne Inc | 2.6% |
| Lam Research Corp | 2.6% |
| Advanced Micro Devices Inc | 2.5% |
| Palo Alto Networks Inc | 2.5% |
| Nebius Group N.V. | 2.5% |
| Credo Technology Group Holding Ltd | 2.3% |
| ASML Holding NV ADR | 2.3% |
| Borsa Italiana | AIAI | EUR |
| XETRA | XMLD | EUR |
| Francoforte | XMLD | EUR |
| London Stock Exchange | AIAG | GBX |
| London Stock Exchange | AIAI | USD |
| SIX Swiss Exchange | AIAI | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.